- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07805395
Building Capacity for Youth Mental Wellness: Family Navigator Model for Foster Parents (FN+)
3 september 2026 bijgewerkt door: Heather Risser, Northwestern University
Building Capacity for Youth Mental Wellness: Feasibility and Acceptability for a Mental Health Family Navigator Model for Foster Parents (FN+ Phase 2)
The investigators have designed a 5-week Family Navigator Plus (FN+) educational program to support foster parents in better understanding their youth's mental health needs and in finding mental health services.
The purpose of this interventional study is to assess the the program's acceptability (e.g., satisfaction, barriers to participation, and burden), utility (e.g., how useful foster parents found the program to be), and feasibility (e.g., number referred who meet eligibility, time to complete assessments, self-reported feasibility), compared to Attention Control (AC).
The investigators hypothesize that our program will be acceptable, useful, and feasible for foster parents of youth with mental health needs.
Studie Overzicht
Toestand
Werving
Interventie / Behandeling
Gedetailleerde beschrijving
We will conduct a pilot RCT (n = 60) as a test of the FN+ Program feasibility and preliminary effectiveness to improve individual-level variables, relative to Attention Control (AC).
The primary outcome will be increased foster parent activation (P-PAM-MH).
Secondary outcomes include reduced barriers to treatment and perceived change in parent capacity to manage youth MH care.
Randomization: We will use simple randomization to assign foster parents to condition.
Foster parents (n=60) will be randomized to the either the FN+ or AC.
We will pilot all randomization procedures including those designed to prevent allocation bias.
Randomization will be conducted by a research analyst who is blind to hypotheses and is not involved in any other aspect of the study.
The research analyst will only share the names and condition assignment with the FNs who do not know study aims or hypotheses and will keep research staff blinded to condition.
The ACHW will conduct all outcome data and remain blind to condition.
The ACHW will remain masked to treatment assignment until the trial is complete.
Success in masking will be monitored using the Evaluator Masking Assessment upon the completion of each data collection time point for each parent.
Inclusion and Exclusion criteria are the same as Aim 2 with the addition that any foster parent that participated in Aim 1 or 2 will be excluded from the RCT.
Studietype
Ingrijpend
Inschrijving (Geschat)
60
Fase
- Fase 2
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studiecontact
- Naam: Heather Risser, PhD
- Telefoonnummer: 3128483019
- E-mail: heather.risser@northwestern.edu
Studie Contact Back-up
- Naam: Christina Boisseau, PhD
- Telefoonnummer: 312-5033270
- E-mail: christina.boisseau@northwestern.edu
Studie Locaties
-
-
Illinois
-
Chicago, Illinois, Verenigde Staten, 60611
- Werving
- Northwestern University
-
Hoofdonderzoeker:
- Heather J Risser, PhD
-
Contact:
- E-mail: heather.risser@northwestern.edu
-
Hoofdonderzoeker:
- Christina Boisseau, PhD
-
Contact:
- Heather Risser, PhD
- Telefoonnummer: 312-848-3019
- E-mail: heather.risser@northwestern.edu
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Ja
Beschrijving
Inclusion Criteria:
- Foster parent, kinship caregiver, or guardian, of a youth between the ages of 6 to 17 with mental health needs
- Parent adopted child from foster care
- Living in Illinois, United States
- English speaking
- Has access to internet and videoconferencing
Exclusion Criteria:
- Participated in the FN+ Focus Groups, Open Trial or PROACTIVE Parent Pilot Study
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Family Navigator Plus
Participants will attend 5 one-on-one sessions over the course of 5 weeks; they will meet with a family navigator over video conferencing software (e.g., Zoom).
The purpose of each sessions are as follows: 1) Provide an overview of the program and help parents understand their perceptions of child behaviors, 2) Train parents to find, access, and overcome barriers to mental health services, 3) Build parent capacity in understanding how mental health treatment works and how to communicate with providers, 4) Help parents understand the common function of child behaviors, and 5) Train parents to find, evaluate, and use online mental health tools.
Participants will complete measures of child symptoms, parent activation, barriers to treatment, and/or satisfaction with the program before the intervention, immediately after the intervention, and 3 months after completing the intervention.
|
Participants will attend 5 one-on-one sessions over the course of 5 weeks; they will meet with a family navigator over video conferencing software (e.g., Zoom).
The purpose of each sessions are as follows: 1) Provide an overview of the program and help parents understand their perceptions of child behaviors, 2) Train parents to find, access, and overcome barriers to mental health services, 3) Build parent capacity in understanding how mental health treatment works and how to communicate with providers, 4) Help parents understand the common function of child behaviors, and 5) Train parents to find, evaluate, and use online mental health tools.
Participants will complete measures of child symptoms, parent activation, barriers to treatment, and/or satisfaction with the program before the intervention, immediately after the intervention, and 3 months after completing the intervention.
|
|
Actieve vergelijker: Civic Engagement Plus
Participants will attend 5 one-on-one sessions over the course of 5 weeks; they will meet with a family navigator over video conferencing software (e.g., Zoom).
The purpose of each sessions are as follows: 1) defines civic engagement within a developmental framework, and guides foster parents in discussing their child's developmental level, strengths, and opportunities for civic participation.
2) identifies developmentally appropriate civic activities and strategies to initiate and support youth involvement.
3) emphasizes goal setting, age-appropriate engagement strategies, collaboration with caseworkers, and structured problem-solving to address barriers to participation.
4) setting developmentally appropriate goals, 5) finding digital tools.
Participants will complete measures of child symptoms, parent activation, barriers to treatment, and/or satisfaction with the program before the intervention, immediately after the intervention, and 3 months after completing the intervention.
|
Participants will attend 5 one-on-one sessions over the course of 5 weeks; they will meet with a family navigator over video conferencing software (e.g., Zoom).
The purpose of each sessions are as follows: 1) defines civic engagement within a developmental framework, and guides foster parents in discussing their child's developmental level, strengths, and opportunities for civic participation.
2) identifies developmentally appropriate civic activities and strategies to initiate and support youth involvement.
3) emphasizes goal setting, age-appropriate engagement strategies, collaboration with caseworkers, and structured problem-solving to address barriers to participation.
4) setting developmentally appropriate goals, 5) finding digital tools.
Participants will complete measures of child symptoms, parent activation, barriers to treatment, and/or satisfaction with the program before the intervention, immediately after the intervention, and 3 months after completing the intervention.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Post Session Questionnaire
Tijdsspanne: Time Frame: After Completing Each Session (Weeks 1 - 5)
|
Description: The Post Session Questionnaire is a measure we created to assess utility and relevance of session content and materials, and to assess if participants intended to use skills/information learned during that session.
Response options range from 1 - 4. Higher scores mean participants found the content more useful.
|
Time Frame: After Completing Each Session (Weeks 1 - 5)
|
|
Client Satisfaction Questionnaire (CSQ)
Tijdsspanne: Time Frame: Post-Intervention (Week 5) and 3 Month Follow Up (Week 18)
|
Description: The Client Satisfaction Questionnaire (CSQ-8) is an eight-item measure that assesses client satisfaction with services including its quality, utility, and relevance.
Response options range from 1 - 4. Higher scores mean participants found to be of high quality, met their needs, etc.
|
Time Frame: Post-Intervention (Week 5) and 3 Month Follow Up (Week 18)
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Parent-Patient Activation Measure - Mental Health
Tijdsspanne: Time Frame: Baseline (Week 1), Post-Intervention (Week 5), 3 month Follow Up (Week 18)
|
Description: The Parent-Patient Activation Measure - Mental Health measures parent activation, defined as the knowledge, ability, and confidence to manage their child's mental health care.
It consists of 13 items on a 4-point Likert-type scale ranging from 1-4.
Item scores are summed for a total composite score ranging from 13 -52.
Composite scores are linearly transformed into scores ranging from 0 - 100.
Higher scores indicate higher activation in managing their child's mental health care.
PP-PAM-MH internal consistency is adequate, alpha = .89;
Item-measures correlations ranged from moderate to large, with a median correlation of .61.
The P-PAM-MH is positively correlated with measures of empowerment and negatively correlated with measures of strain.
|
Time Frame: Baseline (Week 1), Post-Intervention (Week 5), 3 month Follow Up (Week 18)
|
|
Barriers to Treatment Participation Scale
Tijdsspanne: Baseline (week 1), Post-Intervention (week 5), 3 month Follow - Up (week 18)
|
Description: The Barriers to Treatment Participation Scale (BTPS; Kazdin et al., 1997), was designed to assess parent's perceptions of barriers to mental health treatment engagement for their children.
The scale consists of two sections.
The first section contains four subscales that measure the following constructs: stressors and obstacles that compete with treatment (20 items), treatment demands and issues (10 items), perceived relevance of treatment (8 items), and relationship with the therapist (6 items).
Response options for these 44 items range from 1 (Never a problem) to 5 (Very often a problem).
The second section includes 14 discrete events associated with early treatment termination.
Response options for this section include yes and no.
Higher scores on the measure indicate more barriers to treatment participation.
Scores on the BTPS have been associated with multiple indices measuring the child's participation in treatment.
Internal consistency for total score is α =.95, an
|
Baseline (week 1), Post-Intervention (week 5), 3 month Follow - Up (week 18)
|
|
PROMIS Parent Proxy Depressive Symptoms Short Form
Tijdsspanne: Time Frame: Baseline (Week 1), Post-intervention (week 5), 3 month follow up (week 18)
|
Description: The PROMIS Parent Proxy Depressive Symptoms Short Form 8a measures negative mood and views of self, social cognition, and decreased positive affect and engagement in pediatric populations aged 5- to 17-years old (Irwin, et al., 2012).
Parents respond to 8 items assessing their child's symptoms of depression.
Response options range from 1 (never) to 5 (almost always).
Higher scores indicate higher levels of depressive symptoms.
Scores are reported as T-scores ranging from 35-82, with a mean of 50 and standard deviation of 10 in the sample referenced (Irwin et al, 2010).
Higher scores indicate higher levels of depressive symptoms.
Parent proxy measures were created using Item Response Theory to support theoretically maximized reliability and validity across the trait being measured.
Parent proxy scores were strongly univocal with 89% of the general variance explained by the scale's general factor.
Internal consistency is adequate at .90.
|
Time Frame: Baseline (Week 1), Post-intervention (week 5), 3 month follow up (week 18)
|
|
PROMIS Parent Proxy Anxiety Short Form
Tijdsspanne: Time Frame: Baseline (Week 1), Post-intervention (week 5), 3 month follow up (week 18)
|
Description: The PROMIS Parent Proxy Anxiety Short Form 8a measures symptoms of fear, anxious misery, hyperarousal, and somatic symptoms related to arousal among pediatric populations aged 5- to 17-years old (Irwin, et al., 2012).
Parents respond to 8 items assessing their child's symptoms of anxiety.
Response options range from 1 (never) to 5 (almost always).
Higher scores indicate higher levels of anxiety.
Scores are reported as T-scores ranging from 32-84, with a mean of 50 and standard deviation of 10 in the sample referenced (Irwin et al, 2010).
Higher scores indicate higher levels of anxiety.
The measure was created using Item Response Theory to support theoretically maximized reliability and validity across the trait being measured.
The parent proxy version was validated against other proxy measures to ensure content and discriminant validity.
Parent proxy scores were strongly univocal with 87% of the general variance explained by the scale's general factor.
Internal consistenc
|
Time Frame: Baseline (Week 1), Post-intervention (week 5), 3 month follow up (week 18)
|
|
Pediatric Symptom Checklist - 17
Tijdsspanne: Time Frame: Baseline (Week 1), Post-Intervention (Week 5), 3 month Follow Up (Week 18)
|
Description: The Pediatric Symptom Checklist - 17 (PSC-17) was designed to assess psychosocial function in children.
The measures includes three subscales that assess symptoms associated with internalizing, externalizing, and attention problems.
Response options range from 0 (Never) to 2 (Often).
The parent report version is used with children aged 5- to 17- years.
T scores range from 0-34, with at or above 15 indicating the presence of a psychosocial impairment.
Internalizing or Attention subscale scores at or above 5, and Externalizing scores at or above 7, indicate impairment.
The measure has been validated in the general child population.
Parent-reported internal consistency range from .79-.83, and overall reliability as .89.
A large-scale replication study confirmed reliability was high, with both internal consistency and test-retest reliability both at, or above, 0.85 on the parent report form.
|
Time Frame: Baseline (Week 1), Post-Intervention (Week 5), 3 month Follow Up (Week 18)
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Sponsor
Medewerkers
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start (Geschat)
5 september 2026
Primaire voltooiing (Geschat)
30 september 2027
Studie voltooiing (Geschat)
30 september 2027
Studieregistratiedata
Eerst ingediend
1 september 2026
Eerst ingediend dat voldeed aan de QC-criteria
1 september 2026
Eerst geplaatst (Werkelijk)
4 september 2026
Updates van studierecords
Laatste update geplaatst (Werkelijk)
9 september 2026
Laatste update ingediend die voldeed aan QC-criteria
3 september 2026
Laatst geverifieerd
1 september 2026
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- STU00225845
- 5R34MH134941 (Subsidie/contract van de Amerikaanse NIH)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
JA
Beschrijving IPD-plan
Per NIMH Data Sharing policy, de-identified IDP will be shared in the NIMH Data Archive (NDA, https://nda.nih.gov/)
IPD-tijdsbestek voor delen
Per NIMH data sharing policy
IPD-toegangscriteria voor delen
Per NIMH data sharing policy
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Nee
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Nee
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .